|
Center for Molecular Medicine and Genetics
Director:
George Grunberger, MD
3216 Scott Hall
(313) 577-7323
Articles
Published
Abidi
F, Hall BD, Cadle RG, Feldman GL, Lubs HA, Ouzts LV, Arena JF, Stevenson RE,
Schwartz CE. X-linked mental
retardation with variable somatic features (short stature, small head, small
testes) linked to Xq12-q21. American Journal of Medical Genetics, 85:223-229,
1999.
Bachman
NJ, Wu W, Grossman LI, Lomax MI. COX4, the gene for cytochrome
c oxidase subunit IV, and NOC4, a closely linked gene, are controlled by
a bidirectional promoter. Mamm Genome, 10:506-512, 1999.
Berend
SA, Feldman GL, McCaskill C, Czarnecki P, Van Dyke DL, Shaffer LG.
Investigation of two cases of paternal disomy 13 suggests timing of
isochromosome formation and mechanisms leading to uniparental disomy.
American Journal of Medical Genetics, 82:275-281, 1999.
Brady
TB, Kramer RL, Qureshi F, Feldman B, Kupsky WJ, Johnson MP, Evans MI.
Ontogeny of recurrent hydrocephalus:
Presentation in three fetuses in one consanguineous family.
Fetal Diagnosis and Therapy, 14:198-200, 1999.
Brooks
K, Chik L, OÕBrien JE, Critchfield G, Ayoub M, Johnson MP, Evans MI.
Variability of adjustments to indecies in determining risk in biochemical
screening. Fetal Diagnosis and
Therapy, 14:41-46, 1999.
Champagne
N, Bertos NR, Pelletier N, Wang AH, Vezmar M, Yang Y, Heng HHQ, Yang XJ.
Identification of a human histone acetyltransferase related to monocytic
Luekemia zinc finger protein. J
Biol Chem, 274:28528-36, 1999.
Cheng
H-L, Shy ME, Feldman EL. Regulation of insulin like growth factor binding
protein 5 expression during Schwann cell differentiation. Endocrinology,
140:4478-4485, 1999.
Chiu
C-H, Gregoire L, Gumucio DL, Muniz JA, Lancaster WD, Goodman M. The fetal
recruitment of simian (-globin genes: insights from two New World monkeys cebus
apella and callithrix jacchus (Platyrrhini, primates). M Exp Zoology, 285:27-40,
1999.
Claudio
J, Liew C-C, Ma J. Heng HHQ, Stewart K, Hawley R. Cloning and expression
analysis of a novel WD repeat gene, WDR3, mapping to 1p12-p13. Genomics,
59:85-89, 1999.
Devlin
JW, Claire KS, Dulchavsky SA, Tyburski JG.
Impact of trauma stress ulcer prophylaxix guidelines on drug cost and
frequency of major gastrointestinal bleeding.
Pharmacotherapy 19:452-460, 1999.
Di
Carli MF, Bianco-Batlles D, Landa ME, Kazmers A, Groehn H, Muzik O, aGrunberger
G. Effects of autonomic neuropathy
on coronary blood flow in patients with diabetes mellitus.
Circulation, 100:813-819, 1999.
Diebel
LN, Liberati DM, Diglio CA, Dulchavsky SA, Brown WJ.
Synergistic effects of candida and escherichia coli on gut barrier
function. J Trauma 47:1045-1051,
1999.
Drugan
A, Yaron Y, Zamir R, Ebrahim SAD, Johnson MP, Evans MI.
Differential effect of advanced maternal age on prenatal diagnosis of
trisomy 13, 18, and 21. Fetal
Diagnosis and Therapy, 14:181-184, 1999.
Drugan
A, Bronstein M, Itskovitz-Eldor J, Johnson MP, Evans MI.
Ontogeny of isolated ultrasound markers for fetal aneuploidy. Fetal Diagnosis and Therapy, 14:266-269, 1999.
Dulchavsky
SA, Hamilton DR, Diebel LN, Sargsyan AE, Billica RD, Williams DR.
Thoracic ultrasound idagnosis of pneumothorax. J. Trauma 47:970-971, 1999.
Evans
MI, Henry GP, Miller WA, Bui TH, Snidjers RJ, Wapner RJ, Miny P, Johnson MP,
Peakman D, Johnson A, Nicolaides K, Holzgreve W, Ebrahim SAD, Babu R, Jackson L.
International collaborative assessment of 146,000 prenatal karyotypes:
Expected limitations if only chromosome-specific probes and fluorescent
in situ hybridization were used. Human
Reproduction, 14:1213-16, 1999.
Evans
MI, Goldberg J, Horenstein J, Wapner R, Ayoub MA, Stone J, Lipitz S, Achiron R,
Holzgreve W, Brambati B, Johnson A, Johnson MP, Berkowitz R.
Selective termination for structural, chromosomal, and mendelian
anomalies: International
experience. American Journal of
Obstetrics and Gynecology, 181:893-897, 1999.
Feldman
B, Hassan S, Kramer RL, Kasperski SB, Evans MI, Johnson MP.
Amnioinfusion in the evaluation of fetal obstructive uropathy: The effect of antibiotic prophylaxis on complication rates.
Fetal Diagnosis and Therapy, 14:172-175, 1999.
Feldman
B, Yaron Y, Ayoub M, Critchfield G, Dombrowski MP, Leon J, OÕBrien JE, Evans
MI. Distribution of neural tube defects and risks as a function
of maternal weight: No apparent
correlation. Fetal Diagnosis and
Therapy, 14:185-189, 1999.
Fernandez-Madrid
F, VandeVord P, Yang X, Karvonen R, Simpson P, Kraut M, Granda J, Tomkiel J. Antinuclear antibodies as potential markers in the diagnosis
and prognosis of lung cancer. Clin
Cancer Res, 5:1393-400, 1999.
Ford
BD, Loeb JA, Fischbach GD. Neuregulin stimulates DNA synthesis in embryonic
chick heart cells. Dev Biol, 214:139-150, 1999.
Freedman
AL, Smith CA, Evans MI, Gonzalez R, Johnson MP.
Long term outcome in children following antenatal intervention for
obstructive uropathies. Lancet, 354:374-377, 1999.
Fusco
F, Chen Q, Lamoreaux W, Figueredo-Cardenas G, Jiao Y, Coffman J, Surmeier D, Honig M, Carlock L, Reiner A.
Cellular localization of huntingtin in striatal and cortical neurons in
rats: Lack of correlation with neuronal vulnerability in HuntingtonÕs Disease.
J Neurosci, 19:1189-1202, 1999.
Garbern
J, Cambi F, Shy ME, Kamholz J. The molecular pathogenesis of
Pelizaeus-Merzbacher disease. Archives of Neurology, 56:1210-1214, 1999.
Garbern
JY, Cambi F, Lewis R, Shy M, Sima A, Kraft G, Vallat JM, Bosch EP, Hodes ME,
Dlouhy S, Raskind W, Bird T, Macklin W, Kamholz
J. Peripheral neuropathy caused by proteolipid protein gene
mutations. Annals of New York
Academy of Science, 883:351-366,
1999.
Jani
A, Menichella D, Jiang H, Chbihi T, Acsadi G, Shy ME, Kamholz J. Modulation of
cell-mediated immunity prolongs adenovirus-mediated transgene expression in
sciatic nerve. Human Gene Therapy, 10:787-800, 1999.
Jayaraman
G, Srinivas R, Duggan C, Ferreira E, Swaminathan S, Somasundaram K, Williams J,
Hauser C, Kurkinen M, Dhar R, Weitzman S, Buttice G, Thimmapaya B. p300/CBP
interactions with Ets-1 and Ets-2 in the transcriptional activation of the human
stromelysin promoter. J Biol Chem,
274:17342-17352 1999.
Kannan
P, Tainsky MA. The coactivator PC4
suppresses ras-induced tansformation by rstoring AP-2 tanscriptional ativity.
Mol Cell Biol, 19:899-908, 1999.
Kannan
P, Yu Y, Wankhade S, Tainsky MA. Poly ADP-ribose polymerase is a
coactivator for AP-2-mediated transcriptional Activation.
Nucl Acids Res, 27:866-874, 1999.
Kosir
MA, Wang W, Zukowski KL, Tromp G, Barber J. Degradation of basement membrane by
prostate tumor heparanase. Surgical Research, 81:42-47, 1999.
Leach
R, Ko M, Krawetz S. Assignment of amyloid-precursor-like protein 2 gene (APLP2)
to 11q25 by fluorescent in situ hybridization. Cytogenetics Cell Genetics.
87:215-216, 1999.
Lewis
RA, Shy ME. Electrodiagnostic
findings in CMTX: a disorder of the Schwann cell and peripheral nerve myelin. Annals
of the New York Academy of Science, 883:504-508, 1999.
Loeb
JA, Khurana TS, Robbins J, Yee AG, Fischbach GD.
Expression patterns of transmembrane
and released forms of neuregulin during spinal cord and neuromuscular synapse
development. Development, 126:781-791, 1999.
Marchese
A, Sawzdargo M, Nguyen T, Cheng R, Heng HHQ, Nowak T, Im D-S, Lynch K,
George S, OÕDown B. Discovery of three novel orphan G-protein-coupled
receptors. Genomics, 56:12-21, 1999.
Miller
D, Briggs D, Brook P, Snowden H, Hamlington J, Rollinson S,
Lilford R, Krawetz SA. Evidence for a complex population of RNAs in human
ejaculate spermatozoa: implications for understanding molecular aspects of
spermiogenesis. Gene, 237:385-392, 1999.
Monaghan
KG, Feldman GL. The risk of cystic
fibrosis in fetuses with ultrasound evidence of echogenic bowel. Prenat Diag,
19:604-609, 1999.
Olsson
M, Ekblom M, Fecker L, Kurkinen M, Ekblom P.
cDNA cloning and embryonic expression of mouse nuclear pore membrane
glycoprotein 210 mRNA. Kidney Int, 56:827-838. 1999.
Omori
F, Messner HA, Ye J, Nell J, Gronda M, Heng HHQ.
Non-targeted integration of recombinant adeno-associated virus in human
cells detected by fluorescence in situ hybridization.
Human Gene Therapy, 10:537-543, 1999.
Papponen
H, Toppinen T, Baumann P, Myllylä V, Leisti J, Kuivaniemi H, Tromp G, Myllylä
R. Founder mutations and the high
prevalence of myotonia congenita in northern Finland.
Neurology, 53:297-302, 1999.
Pareyson
D, Menichella D, Botti S. Sghirlanzoni A, Fallica E, Mora M, Ciano C, Shy ME,
Taroni F. Heterozygous null
mutation in the PO gene associated with mild Charcot-Marie-Tooth Disease. Annals
of the New York Academy of Science, 883:477-481, 1999.
Park
Eun-Ju, Schroen Daniel J, Yang Maozhou, Li Hui, Li Li, Chen J. Don.
SMRTe, a silencing mediator for retinoid and thyroid hormone
receptors-extended isoform that is more related to the nuclear receptor
corepressor PNAS, 96:3519-3524,
1999.
Quintero
RA, Johnson MP, Mendoza G, Evans MI. The ontogeny of clenched hand development
in trisomy-18 fetuses: a serial transabdominal fetoscopic observation.
Fetal Diagnosis and Therapy, 14:68-70, 1999.
Saini
MS, Diebel LN, Liberati DM, Albaran RG, Dulchavsky SA.
Hemorrhagic shock impairs mucosal immunity to gut-derived antigens. Am Surg 65:637-642, 1999.
Sawzdargo
M, Nguyen T, Lee D, Lynch K, Cheng R, Heng HHQ, George S, OÕDowd B.
Identification and cloning of three novel human G protein-coupled receptor genes
GPR52, GPR53 and GPR55 is extensively expressed in human brain.
Molecular Brain Research, 64:193-198, 1999.
Schmidt
TR, Goodman M, Grossman LI. Molecular evolution of the COX7A gene family in
primates. Mol Biol Evol. 16:619-626. 1999.
Stewart
K, Kramer JA, Evans MI, Krawetz SA. Temporal expression of the transgenic human
protamine gene cluster. Fertility
and Sterility, 71:739-745, 1999.
Stewart
K, Kramer RL, Evans MI, Krawetz SA. Temporal expression of the transgenic human
protameine gene cluster. Fertility and Sterility, 71:739-45, 1999.
Tsai,
CH, Van Dyke DL, Feldman GL. A
child with velocardiofacial syndrome and del(4)9q34.2): another critical region
associated with a velocardiofacial syndrome-like phenotype.
American J Med Genet, 82:336-339, 1999.
Vinas
FC, King PK, Holdener H, Dulchavsky S, Diaz FG.
Outcome and complications of reconstruction of the thoracolumbar spine
for vetbral tumors. J Clin Neurosci
6:467-473, 1999.
Wang
AH, Bertos NR, Vezmar M, Pelletier N, Crosato M, Heng HHQ, ThÕng J, Han J, Yang
XJ. HDAC4, a human histone deacetylase related to yeast HDA1, is a
transcriptional corepressor. Molecular Cell Biology, 19:7816-27, 1999.
Wang
X, Tromp G, Cole CW, Verloes A, Sakalihasan N, Kuivaniemi H.
Analysis of coding sequences for tissue inhibitor of metalloproteinases 1
(TIMP1) and 2 (TIMP2) in patients with aneurysms. Matrix Biology, 18:121-124,
1999.
X-M
Tang, Beesley JS, Grinspan JB, Seth P, Kamholz J, Cambi F.
Cell cycle arrest induced by ectopic expression of p27 is not sufficient
to promote oligodendrocyte differentiation.
J Cell Biochem, 76:270-279, 1999.
Xu
K, Shi ZM, Veeck LL, Hughes MR, Rosenwaks Z.
First unaffected pregnancy using preimplantation genetic diagnosis for
sickle cell anemia. JAMA,
281:1701-1706, 1999.
Yaron
Y, Kramer RL, Feldman B, Kasperski S, Vo T, Feldman GL, Johnson MP, Evans MI,
Ebrahim SA. Prenatal diagnosis of
46, XY/46,XX mosaicism - a case report. Amer
J Med Genet, 84:12-14, 1999.
Yaron
Y, Bryant-Greenwood PK, Dave N, Moldenhauer JS, Johnson KD, Johnson MP, Evans
MI. Multifetal pregnancy reduction (MFPR) of triplets to twins:
Comparison with non-reduced triplets and twins.
American Journal of Obstetrics and Gynecology, 180:1268-71, 1999.
Yaron
Y, Cherry M, OÕBrien JE, Hallak M, Johnson MP, Evans MI.
Second trimester maternal serum marker screening:
MSAFP, B-hCG, estriol, and their various combinations as predictors of
pregnancy outcome. American Journal of Obstetrics and Gynecology, 181:968-974,
1999.
Yaron
Y, Diamond MP, Leach R, Wykes S, BarbourSmith M, Krawetz SA.
Lysyl oxidase transcripts in peritoneal adhesions and incisional scars.
The Journal of Reproductive Medicine, 44:253-256, 1999.
Yaron
Y, Hassan S, Kupferminc MJ, Geva E, Yavetz H, Evans MI.
The evaluation of fetal echogenic bowel in the second trimester.
Fetal Diagnosis and Therapy, 14:176-180, 1999.
Yoon
S, Tromp G, Vongpunsawad S, Ronkainen A, Juvonen T, Kuivaniemi H. Genetic
analysis of MMP3, MMP9 and PAI-1 in Finnish patients with abdominal aortic or
intracranial aneurysms. Biochem Biophys Res Comm, 265:563-568, 1999.
Zachar
V, Zacharova V, Fink T, Thomas RA, King BR, Ebbesen P,
Jones TB, Goustin AS. Genetic analysis reveals ongoing HIV type 1
evolution in infected human placental trophoblast.
AIDS Research and Human Retroviruses, 15:1673-1683, 1999.
Articles
In Press
Ao
A, Ray P, Harper J, Lesko J, Paraschos T, Atkinson G, Soussis I., Taylor D,
Handyside A, Hughes MR, Winston RML. Clinical
experience with preimplantation genetic diagnosis of cystic fibrosis.
Prenatal Diagnosis (in
press)
Briscoe
A.Jr, Tomkiel JE. Chromosomal
position-effects reveal different cis-acting requirements for rDNA transcription
and sex chromosome pairing in Drosophila melanogaster.
Genetics (in press)
Carreno
C, King M, Johnson MP Yaron Y, Diamond M, Bush D, Evans MI.
Treatment of heterotopic cervical and intrauterine pregnancy. Fetal
Diagnosis and Therapy (in press)
Crawford
DC, Schwartz CE, Meadows KL, Newman JL, Taft LF, Gunter C, Bailey Jr, DB, Brown
WT, Carpenter NJ, Howard-Peebles P, Mazzocco MMM, Monaghan KG, Nolin SL, Reiss
AL, Feldman GL, Rohlfs EM, Taylor AK, Warren ST, Sherman SL.
Survey of the fragile X syndrome CGG repeat and STR-and SNP-haplotypes in
an African-American population. Amer J Hum Genet (in press)
Cuesta
IA, Moore E, Rabash R, Bawle EV. Blau Syndrome in an African American family. J
Clin Rheumotol. (in press)
Drugan
A, Johnson MP, Evans MI. Ultrasound
screening for fetal chromosome anomalies. American
Journal of Medical Genetics (in press)
Evans
MI. Genetic Counseling, Screening,
Diagnosis, and Fetal Therapy. Phillipine
Journal of Obstetrics and Gynecology (in
press)
Feldman
B, Ebrahim SAD, Gyi K, Flore LA, Evans MI.
Rapid confirmation of previously detected prenatal mosaicism by
fluorescence in situ hybridization in interphase uncultured amniocytes.
Genetic Testing (in press) and intrauterine pregnancy.
Fetal Diagnosis and Therapy (in press)
Feldman
B, Ebrahim SAD, Hazan SL, Gyi K, Johnson MP, Johnson A, Evans MI.
Routine prenatal diagnosis of aneuploidy by FISH studies in high risk
pregnancies. American Journal of
Medical Genetics (in press)
Feldman
GL, Schuffenecker I, Lenoir G, Saxe AW, Jackson CE.
Variable expressivity of Familial Medullary Thyroid Carcinoma (FMTC) due
to a RET codon 804 (GTG(ATG) mutation in two families: reluctance of gene
carriers to accept prophylactic thyroidectomy. Surgery. (in press)
Haddad
B, Subramanian S, Chong S, Hughes MR. Molecular
genotyping of single cells. Human
Molecular Reproduction (in press)
Jean-Guillaume
D, Awatramani R, Lee A., Mason LM, Lintner RN, Kendler A, Kamholz J, Raine CS,
Dyer CA. GFAP-positive non-myelinating ligodendrocytes in normal and pathologic
adult brain. J. Neurosci Res. (in press)
Krajewski
K, Lewis R, Fuerst D, Turansky C, Hinderer S, Garbern J, Kamholz, J, Shy ME.
Neurological dysfunction and axonal degeneration in CMT 1A, Brain (in
press)
Lewis
RA, Shy ME, Sumner AJ. Electrophysiologic features of inherited demyelinating
neuropathies: a reappraisal. Muscle
and Nerve (in press)
Miller
OJ, Miller DA. Chromosomes. McGraw-Hill Encylcopedia of Science and Technology. (in
press)
Miller
V, Ransom SB, Ayoub MA, Krivchenia EL, Evans MI.
The fiscal impact of a potential legislative ban on second trimester for
prenatally diagnosed abnormalities. American
Journal of Medical Genetics (in press)
Miller
VL, Ransom SB, Shalhoub A, Sokol RJ, Evans MI.
Multifetal pregnancy reduction: perinatal
and fiscal outcomes. American
Journal of Obstetrics and Gynecology (in press)
Monaghan,
KG, Jackson CE, KuKuruga DL, Feldman GL. Mutation
analysis of the cystic fibrosis and cationic trypsinogen genes in patients with
alcohol-related pancreatitis. American Journal of Medical Genetics (in press)
Oh
S Paul, Seki Tsugio, Goss KA, Takeshi I, Yi Y, Donahoe PK, Li L, Dijke PT,
Miyazono K, Kim S, Li E. ALK-1 modulates TGF-beta 1 signalings during vascular
development. PNAS (in press)
Pryde
P, Hallak M, Lauria M, Littman L, Bottoms S, Johnson M, Evans MI.
Severe oligohydramnios with intact membranes: an indication for
diagnostic amnioinfusion. Fetal
Diagnosis and Therapy (in press)
Qureshi
F, Jacques SM, Feldman B, Doss BJ, Johnson A, Evans MI, Johnson MP.
Fetal obstructive uropathy in trisomy syndromes.
Fetal Diagnosis and Therapy (in press)
Rabah
R, Sakr W, Thomas R, Lancaster WD, Gregoire L. Human papillomavirus type,
proliferative activity and P53: potential markers of aggressive papillomatosis.
Arch Pathol Lab Med (in press)
Rabah
R, Lancaster WD, Thomas R, Gregoire L. HPV-11 associated recurrent respiratory
papillomatosis is more aggressive than HPV-6 associated disease. Ped. Develop.
Pathol. (in press)
Ransom
SB, Mickelson IH, Makela PR, Essenmacher L, Evans MI.
The quality of cost-effectiveness and cost-benefit analyses in the
obstetrics and gynecology literature. American
Journal of Obstetrics and Gynecology (in press)
Seubert
DE, Feldman B, Krivchenia EL, Evans MI, Barki J, Johnson MP.
Molecular and fetal tissue biopsy capabilities are needed to maximize
prenatal diangosis of junctional epidermolysis bullosa (JEB):
Fetal skin biopsy using a 2mm microendoscope.
Fetal Diagnosis and Therapy (in press)
Shy
ME, Kamholz J. Hereditary
Neuropathies. Neurobase (in press)
Shy
ME. Axonal loss in inherited demyelinating neuropathies: Lessons from PMP-22
mutant mice. Neurology Network
Commentary (in press)
Sohn
RL, Murray MT, Nyitray J, Purray P, Franko AP, Palmer K, Diebel LN, Hwang P,
Dulchavsky SA. Biolistic delivery
of epidermal growth factor mRNA corrects steroid impaired wound healing. J Molec Med (in press)
Wykes
SM, Miller D, Krawetz SA. Mammalian spermatozoal mRNAs: Tools for functional
analysis of male gametes. Journal
of Submicroscopic Cytology and Pathology (in press)
Xu
W, Manichella D, Jiang H, Vallat J-M, Lilien J, Kamholz J, Shy ME. P0 is
involved in the regulation of myelin gene expression and myelin morphogenesis.
Journal of Neuroscience Research (in press)
Yaron
Y, Rotter V, Aloni R, Schwartz D, Evans MI.
Expression of the p53 tumor suppressor gene in the mouse ovary during an
artificially induced ovulatory cycle. Journal
of Reproductive Medicine (in press)
Books,
Chapters and Reviews
Bui
TH, Jaffe R, Lindholm H, Evans MI. Fetal
spine defects. In, Jaffe R, Bui TH
(eds). Obstetric Ultrasonography:
A Clinical Guide, Parthenon Publishing, London.
pp.199-216, 1999.
Buttino
L Jr., Evans MI, Sibai BM (eds). Study
Guide for Principles and Practices of Medical Therapy in Pregnancy-3rd Edition.
Appleton and Lange Publishing Co., Norwalk, Connecticut, 1999.
Drugan
A, Feldman B, Johnson MP, Evans MI. Prenatal
Diagnosis: Procedures and trends.
In, Avery GB, MacDonald M, Fletcher MA (eds).
Neonatology: Pathophysiology
and management of the newborn, 5th Edition.
Lippincott Williams & Wilkins, Philadelphia pp.
161-171, 1999.
Dulchavsky
SA, Schwartz SI. Alexander J. Walt
Memoirs. Wayne State University
Press. Detroit, 1999.
Evans
MI, Yaron Y, Lewis P, Hume RF. Fetal
Pharmacologic Therapy. In, Kurjak
A, Nicolaides K, et al (eds). Textbook
of Perinatal Medicine. Parthenon
Publishing, London, pp. 1065-1072, 1999.
Evans
MI, Johnson MP. Multifetal
pregnancy reduction. In, Reece EA,
Hobbins J (eds). Medicine of the
Fetus and Mother. 2nd Edition, Lippincott/Raven, Philadelphia, pp. 1433-1438,
1999.
Evans
MI. Overview of Fetal Therapy.
In: New M (ed).
Diagnosis and Treatment of the Unborn Child, Idelson-Gnocchi, Ltd.
Reddick, FL, pp.133-136, 1999.
Evans
MI. Techniques for Hematopoietic
Stem Cell Transfer. In:
New M (ed). Diagnosis and
Treatment of the Unborn Child, Idelson-Gnocchi, Ltd. Reddick, FL, pp.137-139,
1999.
Evans
MI, OÕBrien JE, Johnson A. Screening
for Aneuploidy. In, (eds).
Current Opinion in Obstetrics and Gynecology 1/2.
Lippincott, Williams & Wilkins, London, pp 115-118, 1999.
Evans
MI, Yaron Y, Littmann L, Tapin C, Belkin HR.
Issues in multifetal pregnancy reduction.
In, Chervenak F, Kurjak A (eds). Fetal
Medicine: The Clinical Care of the
Fetus as a Patient. Parthenon
Publishing, London, pp 136-150, 1999.
Evans
MI, Flake AW, Johnson MP, Belkin HR, Johnson A, Harrison M.
In utero treatment: state of
the art. In, Chervenak F, Kurjak A
(eds). Fetal Medicine: The Clinical Care of the Fetus as a Patient,
Parthenon Publishing, London. pp. 186-204, 1999.
Evans
MI, Evans WJ, Johnson MP. Ethics of
Reproduction. In, Tierney H (ed).
WomenÕs Studies Encyclopedia. Greenwood
Publishing Co, Westport, CT. pp. 1206-1221, 1999.
Evans
MI, OÕBrien JE, Dvorin E, Critchfield G. Screening
for aneuploidy. In, Queenan JJ
(ed). Management of High Risk
Pregnancy, 4th Edition Blackwell
Science, Massachusetts, pp 119-135, 1999.
Evans
MI, Hume RF, Yaron Y, Kramer RL, Johnson MP.
Reduction of high multiple pregnancies.
In, Neilson B, Ballieres JP (eds). Clinical
Obstetrics and Gynecology , J. B. Lippincott, Philadelphia, PA. pp. 147-159,
1999.
Evans
MI, Harrison M, Johnson MP, Feldman B, Holzgreve W.
Fetal Therapy. In,
Avery Gb, MacDonald M, Fletcher MA (eds). Neonatology:
Pathophysiology and management of the newborn, 5th Edition.
Lippincott Williams & Wilkins, Philadelphia pp. 173-185, 1999.
Evans
MI, Johnson MP. Multifetal
pregnancy reduction and selective termination.
In, James DK, Star PJ, Weiner CP, Gonik B (eds).
High Risk Pregnancy: Management
Options. WB Saunders, London,
England. pp. 243-248, 1999.
Evans
MI, King M, Hoffman E, Holzgreve W. Fetal
Tissue Biopsies. In, James DK,
Star PJ, Weiner CP, Gonik B (eds). High
Risk Pregnancy: Management Options.
WB Saunders, London, England. pp. 235-241, 1999.
Evans
MI, Johnson MP. Genetics and
Prenatal Diagnosis. In, Dombrowski
MP, Ransom SB, McNeeley SG, Diamond MP, Munkarah AR (eds)
Practical Strategies in Obstetrics and Gynecology, W. B. Saunders
Publishing Co., Philadelphia, PA, pp 213-223, 1999.
Evans
MI, Yaron Y, Kramer RL, Johnson MP. Options
following the diagnosis of a fetal anomaly.
In, McCormick MC (ed). Prenatal
Care: Effectiveness and
Implementation, Cambridge University Press, Cambridge, England, pp 244-258,
1999.
Evans
MI. Editorial.
Current Opinion in Obstetrics and Gynecology 11:13-14, 1999.
Evans
MI, Screening for aneuploidy. Current
Opinion in Obstetrics and Gynecology 11(2):115-18, 1999.
Evans
MI, Johnson A, Gilbert AD. The
future of chromosome screening: ultrasound, biochemistry, or both.
Frontiers in Fetal Health: A Global Perspective 1(1):16, 1999.
Fernandez-Madrid
F and Tomkiel J. ÒAntinuclear
Antibodies and Lung CancerÓ in Autoimmunity
and Cancer, Ed. Y. Schoenfeld. Springer-Verlag,
Berlin. 1999.
Garbern
J, Lewis R, Bosch EP, Sima A, Shy M, Menichella D, Vallat J-M, Cambi F, and
Kamholz J. Peripheral neuropathy caused by mutations of the proteolipid
protein gene. In: Charcot-Marie-Tooth disorders. Shy M. and Kamholz J. eds.
Annals of the New York Academy of Science 883: 351-365, 1999.
Grunberger
G. Diagnosis and evaluation of the diabetic patient with
erectile dysfunction. Current
Concepts in the Management of Erectile Dysfunction 1: 2-3, 1999.
Isada
NB, Martin LS, Evans MI. Prenatal
diagnosis in the molecular age. In,
Avery GB, MacDonald M, Fletcher MA (eds). Neonatology:
Pathophysiology and management of the newborn, 5th Edition.
Lippincott Williams & Wilkins, Philadelphia. pp. 111-123, 1999.
Jani
A, Menichella D, Jiang H, Acsadi G, Kamholz J, and Shy ME. Overcoming cellular
immunity to prolong adenoviral mediated gene expression in sciatic nerve. In:
Charcot-Marie-Tooth disorders. Shy M. and Kamholz J. eds. Annals of the New York
Academy of Science 883: 397-414, 1999.
Kamholz
J, Awatramani R, Menichella D, Jiang H. Xu W, and Shy ME. Regulation of
myelin-specific gene expression: relevance to CMT1. In: Charcot-Marie-Tooth
disorders. Shy M. and Kamholz J. eds.
Annals of the New York Academy of Science 883: 91-109, 1999.
Krajewski
K, Turansky C, Lewis R, Garbern J, Hinderer S, Kamholz J, and Shy ME.
Correlation between weakness and axonal loss in patients with CMT1A. In: Charcot-Marie-Tooth
disorders. Shy M. and Kamholz J. eds. Annals of the New York Academy of Science
883: 490-492, 1999.
Krawetz
SA, Kramer JA and McCarrey JR. Reprogramming the male gamete genome: a window to
successful gene therapy. Gene
234:1-9, 1999.
Menichella
DM, XuW, Jiang H, Sohi J, Vallat JM, Baron P, Kamholz J, and Shy ME. The absence
of myelin P0 protein produces a novel molecular phenotype in Schwann cells. In:
Charcot-Marie-Tooth disorders. Shy M. and Kamholz J. eds. Annals of the
New York Academy of Science 883: 281-294, 1999.
Murray
MT and Reinbold R. ÒIsolation and characterization of maternal mRNPs from
Xenopus oocytesÓ in A Comparative Methods Approach to the Study of Oocytes and
Embryos. Ed. Richter J, Oxford University Press, p. 227-240, 1999.
Rodeck
CH, Whittle MJ, Ferguson M, Hanson M, Bewley S, Nelson R, Holzgreve W, Evans MI,
Benacerraf B, Trudinger B, Chiswick M (eds).
Fetal Medicine: Basic
Science and Clinical Practice. Churchill
Livingstone, London, England, 1999
Chapter
62 Lewis P, Yaron Y, Evans MI.
Diagnosis and treatment of fetal endocrine disorders, pp 829-834
Chapter
44 Evans MI, Krivchenia EL, King M,
Hoffman E. Muscular dystrophy, pp.
519-524
Chapter
66 Dommergues M, Aubry MC, Mahieu-Ceputo D,
Evans MI, Dumez Y. Multifetal pregnancy reduction and selective termination, pp
879-886.
Shy
ME, Kamholz J, and Lovelace RE, eds. Charcot-Marie-Tooth disorders. Annals of
the New York Academy of Science, Volume 883, 1999.
Shy
ME, Kamholz J, and Lovelace RE. Introduction to the 3rd International Conference
on Charcot-Marie-Tooth disorders. In: Charcot-Marie-Tooth
disorders. Shy ME and Kamholz J. eds. Annals of the New York Academy of Science
883: xiii-xviii, 1999.
Yaron
Y, Evans MI. Fetal metabolic and gene therapy.
In, Reece EA, Hobbins J (eds). Medicine
of the Fetus and Mother. 2nd Edition, Lippincott/Raven, Philadelphia, pp.
873-890, 1999.
Yaron
Y, Flake AW, Johnson MP, Evans MI. Fetal stem cell and gene therapy.
In, Kurjak A, Nicolaides K, et al (eds).
Textbook of Perinatal Medicine. Parthenon
Publishing, London, pp. 1093-1103,
1999.
Books
and Chapters in Press
Evans
MI, Rodeck CH (eds). Ultrasound and
Fetal Therapy. Parthenon Publishing
Co., London, England, (in press).
Chapter
1 Johnson MP, Feldman B, Evans MI.
Fetal shunt procedures, pp. 1-18
Chapter
8 Evans MI, Hume RF, Lewis P, Feldman B,
Yaron Y. Pharmacologic fetal
therapy, pp 95-104.
Chapter
9 Yaron Y, Flake AQ, Zanjani E,
Johnson MP, Evans MI. Stem Cell Fetal Therapy, pp 105-112. Evans MI, (ed).
Prenatal Diagnosis: Genetics,
Reproductive Risks, Testing, and Managment.
Appleton and Lange Publishing Co., Norwalk, Connecticut, (in press).
Chapter
35 Evans MI, Rodeck CH, Holzgreve W,
et al. CVS
Chapter
37 Evans MI, et al.
Tissue biopsies
Chapter
42 Evans MI, et al.
Biochemical screening
Chapter
54 Evans MI, Rodeck CH, et al.
Selective termination
Evans
MI, Platt LD, de la Cruz F (eds). Fetal
Therapy. Parthenon Publishing
Company, London
Chapter
Evans MI. Metabolic therapy,
(in press).
Evans
MI, Ginsburg KA (eds). Pretest:
Obstetrics and Gynecology, 9th Edition.
McGraw-Hill, New York, (in press).
Evans
MI, et al. Fetal Therapy and Fetal Surgery.
In, Gabbe SG, Niebyl JR, Simpson JL (eds.) Obstetrics:
Normal and Problem Pregnancies, 4th Edition, W. B. Saunders, New York,
(in press).
Evans
MI, et al. Fetal muscle biopsy. In,
Quintero RA (ed). Diagnostic and
Operative Fetoscopy, Parthenon Publishing Co., New York, (in press).
Evans
MI and Levy, H. The future of newborn screening belongs to obstetricians.
In, Simonsen & B. Norgaard-Pedersen (ed). Neonatal screening in the next millenium.
Proceedings of the 4th meeting of the international society for neonatal
screening. Scandinavian University
Press, Oslo, (in press).
Evans
MI, Dvorin E, Bui TH, OÕBrien JE. Biochemical screening for aneuploidy.
In: Sciarra J (ed).
Gynecology and Obstetrics. Lippincott
Raven Publishing Co., Philadelphia, (in press).
Harrison
MR, Evans MI, Adzick NS, Holzgreve W (eds).
The Unborn Patient: The Art
and Science of Fetal Therapy, 3rd Edition.
W.B. Saunders Publishing Company, Philadelphia, (in press).
Holzgreve
W, Tercanli S, Evans MI, Miny P. Placental biopsies for rapid karyotyping in the
second and third trimesters (late CVS) in high risk pregnancies. In, Antsaklis
AJ (ed), Prenatal Diagnosis and
Fetal Treatment, (Greek), (in press).
Johnson
MP, et al. Lower urinary tract
assessment. In, Quintero RA (ed). Diagnostic
and Operative Fetoscopy, Parthenon Publishing Co., New York, (in press).
Kuivaniemi
H and Tromp G. Search for the aneurysm susceptibility gene(s). In: Development
of Aneurysms. Richard Keen and Philip Dobrin, editors, Landes Bioscience,
Georgetown, Texas, (in press).
Miller
OJ and Therman E. Human
Chromosomes, 4th Edition. Springer-Verlag, New York, (in press).
Ransom
SB, Dombrowski MP, Evans MI (eds). Contemporary
Therapy in Obstetrics and Gynecology. W.
B. Saunders Publishing Company, Philadelphia, (in press).
Shy
ME. Inherited Neuropathies, in Peripheral Neuropathy Syllabus, for annual
American Academy of Neurology course on Peripheral Neuropathies, (in press).
Shy
ME and Lewis RA. Inherited Neuropathies. Neuroscular Diseases. Buttermworth-Heinemann,
(in press).
Victorina
WM and G Grunberger: Thiazolidinediones: Finally treating the disease. Practical
Diabetology, (in press).
Wykes
SM. and Krawetz SA, Gene Potentiation: Forming long-range open
chromatin structures. Gene Therapy and Molecular Biology, (in press).
Abstracts
Published
Bawle
EV, Moestrup SK. Normal size cubilin in a patient with megaloblastic anemia. Am
J Hum Genet Suppl 65:A231, 1999.
Boucher
S, Carlock L, Skoff R. PLP regulates survival and death of neurons. Great Lakes
Glia Meeting, Thompsonville, MI 1999.
Cambi
F, Garbern J, Shy M, Kamholz J. X-linked
spasticity syndromes caused by mutations in the PLP gene. J Neurochem, 72,:S17,
1999.
Carreno
CA, Yaron Y, Feldman B, Treadwell M, Johnson MP, Ayoub MA, Evans MI.
First trimester embryo size discordancy: A predictor of prematurity following multifetal pregnancy reduction
(MFPR). Society for Maternal Fetal
Medicine Annual Meeting. San Francisco, CA, January 18-23, 1999. American
Journal of Obstetrics and Gynecology 180:S104,
1999.
Chik
L, Spencer K, OÕBrien JE, Sokol R, Macri J, Pandian R, Evans MI.
Disparities in risk estimates for Down syndrome (DS) in biochemical
screening: A comparison of methods
on decision cut-points. Society for
Gynecologic Investigation, 46th Annual Meeting. Atlanta, GA, March 10-13, 1999.
Journal of the Society for Gynecologic Investigation, 6:99A, 1999.
Cypher
M, Perry C, Nguyen M, Skoff R, Carlock L. Protein
processing and cell death in transfected and stable cell lines expressing normal
or mutant PLP/DM20 proteins. 30th Annual Meeting, New Orleans, LA 1999
Cypher
MA, Perry C, Nguyen M, Skoff R, Carlock L.
Comparison of normal and mutant PLP/DM20 protein transport with cell
death in transfected and stable cell lines expressing normal or mutant PLP/DM20-EGFP
fusion proteins. European Soc. for Dysmyelinating Diseases. (Padua, Italy) 1999.
Cypher
MA, Kerwin S, Perry C, Skoff R, Carlock L.
Examining transport and processing of normal and mutant PLP/DM20 proteins
in stable cell lines. Great Lakes
Glia Meeting, Thompsonville, MI, 1999.
de
la Cruz F, Shifrin H, Elias S, Bianchi DW, Jackson L, Evans MI, Simpson JL,
Holzgreve W, Klinger K. Low false
positive rates of aneuploidy detection using fetal cells isolated from maternal
blood. Fetal Diagnosis and Therapy,
13(6):380, 1999.
Decker
AB, Coccia CT, Feldman GL. First
report of two siblings with apparently isolated odontohypophosphatasia: Dominant
or recessive inheritance. Amer J of
Hum Genet, 65:A146. 1999.
Diebel
LN, Liberati DM, Diglio CA, Saini MS, Dulchavsky SA. Alcohol effect on
intestinal barrier function and inflammatory cytokine production.
The Western Trauma Association, 29th Annual Scientific Meeting, Crested
Butte, CO. February 28-March 6, 1999.
Drugan
A, Avrahami R, Zamir R, Itskovitz-Eldor J, Sokol RJ, Evans MI.
Fetal gender impact on incidence and implications of sonographic markers
for Down syndrome (SMDS). Society
for Maternal Fetal Medicine Annual Meeting. San Francisco, CA, January 18-23,
1999. American Journal of
Obstetrics and Gynecology, 180:S172,
1999.
Drugan
A, Feldman B, Ebrahim SAD, Johnson MP, Krivchenia EL, Kasperski S, Evans MI.
Differential impact of age, ultrasound, and biochemical screening on
aneuploid detection. Society for Gynecologic Investigation, 46th Annual Meeting.
Atlanta, GA, March 10-13, 1999. Journal
of the Society for Gynecologic Investigation,
6:99A, 1999.
Evans
MI, Wapner R, Carpenter R, Goldberg J, Timor-Tritsch IE, Ayoub MA, Stone J,
Horenstein J, Snijders R, Dommergues M, Brambati B, Nicolaides K, Holzgreve W,
Tuliu L, Lerner J, Dumez Y, Monteagudo A, Johnson MP, Berkowitz R.
International collaboration on multifetal pregnancy reduction (MFPR):
Dramatically improved outcomes with increased experience.
Society for Maternal Fetal Medicine Annual Meeting. San Francisco, CA,
January 18-23, 1999. American
Journal of Obstetrics and Gynecology, 180:S28,
1999.
Evans
MI, Goldberg J, Horenstein J, Wapner R, Ayoub MA, Stone J, Lipitz S, Achiron R,
Holzgreve W, Brambati B, Johnson A, Johnson MP, Berkowitz R.
Selective termination (ST) for structural (STR), chromosomal CHR), and
Mendelian (MEN) anomalies: International
experience. Society for Maternal
Fetal Medicine Annual Meeting. San Francisco, CA, January 18-23, 1999.
American Journal of Obstetrics and Gynecology, 180:S31, 1999.
Evans
MI, Nicolaides K, Goldberg JD, Wapner RJ, Horenstein J, Dommergues M, Holzgreve
W, Timor-Tritsch I, Carpenter R, Baker C, Ayoub M, Shaloub A, Brambati B,
Snijders R, Monteagudo A, Berkowitz R.
Birth weight discordancy among remaining fetuses after multifetal
pregnacy reduction (MFPR) and selective termination :
Correlation with starting number. Society for Gynecologic Investigation,
46th Annual Meeting. Atlanta, GA, March 10-13, 1999.
Journal of the Society for Gynecologic Investigation,
6:5A, 1999.
Evans
MI, Wapner RJ, Timor-Tritsch I, Carpenter R, Goldberg JD, Nicolaides K,
Dommergues M, Dumez Y, Horenstein J, Stone J, Ayoub M, Shalhoub A, Baker C,
Monteagudo A, Snijders R, Berkowitz R. Methods
of initiation of multifetal pregnancies: Implications
for outcomes following multifetal pregnancy reduction.
Society for Gynecologic Investigation, 46th Annual Meeting. Atlanta, GA,
March 10-13, 1999. Journal of the
Society for Gynecologic Investigation, 6:213A,
1999.
Evans
MI, Carpenter R, Goldberg JD, Johnson A, Nicolaides K, Holzgreve W, Berkowitz RL,
Timor-Tritsch I, Wapner RJ. Collaborative multifetal pregnancy outcomes (MFPR): outcomes and fetal growth.
International Fetal Medicine and Surgery Society.
Carlisle Cumbria, UK, May 19-23, 1999.
Evans
MI, Goldberg J, Ayoub MA, Liptz S, Johnson A, Berkowitz R.
Second trimester selective termination update. International Fetal
Medicine and Surgery Society. Carlisle
Cumbria, UK, May 19-23, 1999.
Feldman
B, Hazan SL, Ebrahim SAD, Krivchenia EL, Johnson MP, Evans MI.
Pseudomosaicism from maternal cell contamination is much more prevelent
with cytogenetically abnormal fetuses. Society
for Maternal Fetal Medicine Annual Meeting. San Francisco, CA, January 18-23,
1999. American Journal of
Obstetrics and Gynecology, 180:S56, 1999.
Feldman
B, Hazan SL, Ebrahim SAD, Krivchenia EL, Drugan A, Johnson MP, Evans MI.
Pregnancy outcomes of confined placental mosaicism Ð a 10 year study.
Society for Maternal Fetal Medicine Annual Meeting. San Francisco, CA,
January 18-23, 1999. American
Journal of Obstetrics and Gynecology, 180:S56, 1999.
Feldman
B, Ebrahim SAD, Gyi K, Ayoub MA, Johnson MP, Dombrowski MP, Evans MI.
Utilization of fluorescent in situ hybridization for diagnosis of
abnormal fetal karyotypes other than aneuploidy.
Society for Maternal Fetal Medicine Annual Meeting. San Francisco, CA,
January 18-23, 1999. American
Journal of Obstetrics and Gynecology, 180:S57, 1999.
Feldman
B, Ebrahim SAD, Gyi K, Johnson A, Johnson MP, Evans MI.
Routine prenatal diagnosis of aneuploidy by FISH studies in high risk
pregnancies. International Fetal
Medicine and Surgery Society. Carlisle
Cumbria, UK, May 19-23, 1999.
Feldman
GL, Schuffenecker I, Lenoir GM, Saxe AW, Roberson JR, Petrucelli N, Jackson CE. Variable expressivity of Familial Medullary Thyroid Carcinoma
(FMTC) due to a RET V804M (GTG(ATG) mutation in two families: reluctance of gene
carriers to accept prophylactic thyroidectomy. Genet in Med, 1:45. 1999.
Finley
Jr RL, Zhong J. Towards a Drosophila genome-wide protein interaction map.
Abstract. 40th Annual Drosophila Research Conference, Seattle, WA March 1999.
Fitzgerald
J, Anderson R, Funnell M, Gruppen L, Grunberger G, Jacober S, Aman L.
Perceptions and attitudes in type 2 diabetes by treatment and ethnicity.
Diabetes 48; Supp 1: A324, 1999.
Flack
JM, Staffileno BA, Hamaty M, Kuivaniemi H, Tromp G, Dudley A, Grimm RH.
Angiotensin converting enzyme gene polymorphism influences blood pressure
response to dietary sodium in normotensive African-Americans. Circulation,
99:1110, 1999.
Garbern
JY, Heng HHQ, Wu R-P, Ye CJ, Awatraman R, Kamholz J. The human GTX gene maps to
10q26, a region often deleted in gliomas. in American Society for Human
Genetics, 65, Program Nr: 1022, 1999.
Gregoire
L, Munkarah A, Rabah R, Lancaster WD. In
vitro malignant transformation of HPV-16 E6/E7 immortalized human ovarian
surface epithelial cells. American Association for Cancer Research,
Philadelphia, PA. 1999.
Grossman
LI, Wu W, Schmidt TR, Goodman M. Novel evolutionary interaction of cytochrome c
and cytochrome c oxidase in higher primates. Gordon Research Conference on
Bioenergetics, Proctor Academy, Andover, NH, June 27-July 2, 1999.
Grossman
LI, Wu W, Schmidt TR, Goodman M. Novel evolutionary interaction of cytochrome c
and cytochrome c oxidase in higher primates. 4th European Meeting on
Mitochondrial Pathology, Cambridge, September 16-19, 1999.
Grunberger
G, WM Weston, R Patwardhan, and EB Rappaport: Rosiglitazone once or twice daily
improves glycemic control in patients with type 2 diabetes.
Diabetologia 42, Suppl 1: A4, 1999.
Grunberger
G, WM Weston, R Patwardhan, and EB Rappaport: Rosiglitazone once or twice daily
improves glycemic control in patients with type 2 diabetes. Diabetes 48; Suppl
1: A102 1999.
Hao
H-N, Thomas RA, Zhao J, Abdel-Haq N, Lyman WD.
HIV passaged through microglia changes its chemokine receptor
specificity. A P8-2, Am Soc for Virology 18th Ann Meeting, Univ of
Massachusetts, July 10-14, 1999.
Hao
H-N, Thomas RA, Abdel-Haq N, Zhao J, Lotoczky WE, Grever WE, Lyman WD.
Enhancement of Neuronal Toxicity by Exogeneous HIV-1 tat in Mixed Astrocyte/Neuronal
Cultures. A 906.15, Soc for Neurosci 29th Ann Meeting, Miami Beach, October
23-28, 1999.
Heng
H, Krawetz SA, Liu G, Bremer S, Moens P, Spyropoulos B.
Novel Features of chromatin loop structure and its formation. Center for
Molecular Medicine & Genetics Wayne State University Scientific Retreat
Maumee Bay, 1999.
HŸttemann
M, MŸhlenbein, Schmidt TR, Grossman LI, Kadenback B. Defective splicing of the
subunit VIIaL gene of cytochrome c oxidase in a patient with Leigh syndrome. 4th
European Meeting on Mitochondria Pathology, Cambridge, September 16-19, 1999.
Johnson
A, Leach R, Johnson MP, Lee H, Qureshi F, Hassan S, Romero R, Evans MI.
Selective termination using bipolar cautery: the Detroit experience.
International Fetal Medicine and Surgery Society.
Carlisle Cumbria, UK, May 19-23, 1999.
Johnson
A, Leach R, Lee HM, Richter R, Qureshi F, Jacques SM, Romero R, Hassan S, Sokol
RJ, Evans MI. Bipolar Coagulation (BPF):
An Improved Method of Selective Termination in Complicated Monochorionic Twin
Pregnancies. Central Association of
Obstetricians and Gynecologists. 1999 Annual Meeting, Maui, HI, October 25-30,
1999.
Johnson
MP, Feldman B, Kasperski S, Qureshi F, Jacques S, Gonzalez R, Evans MI.
Prenatal evaluation and shunting for fetal obstructive uropathy:
Management of nearly 100 cases. Society
for Maternal Fetal Medicine Annual Meeting.
San Francisco, CA, January 18-23, 1999.
American Journal of Obstetrics and Gynecology, 180:S30, 1999.
Johnson
MP, Romero R, Edwin SS, Feldman B, Kasperski S, Qureshi F, Evans MI.
Evidence for differential expression of growth factors and cytokinse in
the urine of fetuses with obstructive uropathy. Society for Maternal Fetal Medicine Annual Meeting.
San Francisco, CA, January 18-23, 1999.
American Journal of Obstetrics and Gynecology, 180:S11, 1999.
Khan
O, Tselis A, Garbern J, Kamholz J, Lisak R. Clinical profile of relapsing
multiple sclerosis in African Americans: Impact of immunomodulating therapy on
disease course. Ann Neurol, 46, 471, 1999.
Kolonin
MG, Finley Jr RL. Analysis of cyclin J function with peptide aptamers. Abstract.
40th Annual Drosophila Research Conference, Seattle, WA March 1999.
Krajewski
K, Shein N, Watson C, Fuerst D, Kamholz J, Garbern J, Shah J, Shah A, Chugani
HT. The genetics of hippocampal sclerosis. Epilepsia 40, 234,
1999.
Kramer
RL, Comeaux Ty, Kowalczyk CL, Yaron Y, Feldman B, Johnson MP, Evans MI.
Ovulation induction influences maternal serum markers for Down syndrome and
neural tube defects. Society for
Maternal Fetal Medicine Annual Meeting. San
Francisco, CA, January 18-23, 1999. American Journal of Obstetrics and
Gynecology, 180:S56, 1999.
Kramer
JA, McCarrey JM, Djakiew D, Krawetz SA. Selective
gene potentiation during mammalian spermatogenesis. Great Lakes Mammalian
Development Meeting 1999, Toronto, Ontario, Canada, 1999.
Kramer
RL, OÕBrien JE, Dombrowski MP, Drugan A, Feldman B, Ayoub MA, Evans MI.
Insufficient power to verify the accuracy of risk predictions in
biochemical screening even in the worldÕs largest databases.
Society for Gynecologic Investigation, 46th Annual Meeting. Atlanta, GA,
March 10-13, 1999. Journal of the Society for Gynecologic Investigation, 6:99A,
1999.
Krawetz
SA. Reprogramming a segment of chromosome 16 for male gamete expression and
fertilization. ÒGene Therapy and Molecular Biology International ConferenceÓ
Crete, Greece, 268-271, 1999.
Kuivaniemi
H, Yoon S, Thatai D, Marsh J, Malcom
GT, Strong JP, McMahan CA, Tromp G. Plasminogen
activator inhibitor-1 is not associated with the amount of fibrous plaque in
arteries, but contributes to increased risk of heart attack. Circulation,
99:1116, 1999.
Lewis
D, Bischoff, Simpson JL, Elias S, Bianchi D, Klinger K, Dukes K, Sullivan L,
Evans M, Holzgreve W, Hahn S, Jackson L, Wapner R, de la Cruz F, Shifrin H.
Multicenter study of fetal cell recovery from maternal circulation and
analysis. 49th Annual Meeting of
the American Society of Human Genetics, San Francisco, CA October 10-23, 1999.
Martins
RP, Krawetz SA. Characterization of the human lysyl oxidase locus: a model to
study the mechanism of gene potentiation. Center for Molecular Medicine &
Genetics, Wayne State University, Scientific Retreat Maumee Bay B-6, 1999.
Mathews
ST, Srinivas PR, Grunberger G, Goustin AS.
Role of MAP kinase signaling pathways in RSK2 activation in vascular
smooth muscle cells. FASEB J
13:A1489, 1999.
Miller
V, Ransom SB, Ayoub MA, Krivchenia EL, Evans MI.
The fiscal impact of a potential legislative ban on second trimester
medically indicated abortions. Society
for Maternal Fetal Medicine Annual Meeting. San Francisco, CA, January 18-23,
1999. American Journal of
Obstetrics and Gynecology, 180:S57, 1999.
Miller
VL, Ransom SB, Shalhoub A, Sokol RJ, Evans MI.
Multifetal Pregnancy Reduction: Perinatal
and Fiscal Outcomes. Central
Association of Obstetricians and Gynecologists.
1999 Annual Meeting, Maui, HI, October 25-30, 1999.
Monaghan,
KM, Jackson CE, Feldman GL. Genetic
analysis of patients with pancreatitis and a history of alcohol abuse.
Genet in Med, 1:49. 1999.
Perry
C, Nguyen M, Cypher M, Carlock L. Strong
correlation between polyglutamine repeat size in the huntington disease gene and
the disease phenotype. Am Soc Neurochem, 30th Annual Meeting, New Orleans, LA.
1999.
Ransom
SB, Mickelson IH, Makela PR, Essenmacher L, Evans MI.
The Quality of Cost-Effectiveness and Cost-Benefit Analyses in the
Obstetrics and Gynecology Literature. Central
Association of Obstetricians and Gynecologists.
1999 Annual Meeting, Maui, HI, October 25-30, 1999.
Reddy
U, Ayoub MA, Evans MI, Wapner RJ . Multiple
gestations: Ultrasound diagnosis of
trisomy 21. Society for Maternal
Fetal Medicine Annual Meeting. San Francisco, CA, January 18-23, 1999. American Journal of Obstetrics and Gynecology, 180:S167,
1999.
Ruffin
M, Brenner D, Reed B, Normele D. Gregoire L, Munkarah A, Kmak T, Lancaster WD.
The potential use of HPV copy number and E6/E7 expression as biomarkers in
cervical dysplasia. American
Association for Cancer Research, Philadelphia, PA. 1999.
Ryou
C, Kadura I, Miller RE, Hadden TJ. The
glutamine synthetase intron-1 regulatory region includes a constitutive enhancer
and two preadipocyte-specific silencers. American
Society for Biochemistry & Milecular Bilogy, 1999 Annual Meeting; San
Francisco, CA May 16-20. FASEB J
13, 1999
Salkowski
A, Greb A, Al-Aouar R, Tromp G, Berguer R, Olson J, Kuivaniemi H.
Familial incidence of abdominal aortic aneurysms. J Genetic Counseling,
8:407, 1999.
Seubert
DE, Feldman B, Krivchenia EL, Evans MI, Barki J, Johnson MP.
Molecular and fetal tissue biopsy capabilities are needed to maximize
prenatal diagnosis of junctional epidermolysis bullosa (JEB):
Fetal skin biopsy using a 2mm microendoscope.
Society for Maternal Fetal Medicine Annual Meeting. San Francisco, CA,
January 18-23, 1999. American
Journal of Obstetrics and Gynecology, 180:S182, 1999.
Shy
ME, Krajewski K, Turansky C, Garbern J, Kamholz JA, Lewis R. CMT1A phenotype
correlates with secondary axonal degeneration but not demyelination. Neurology
52:A217, 1999.
Srinivas
PR, Cintron VJ, Sima AF, Grunberger G. Primary
cultures of vascular smooth muscle cells from the BB/W type 1 diabetic rat
retain their hyperglycemic memory. Diabetes 48; Suppl 1: A132, 1999.
Thomas
RA, Bergh S, Zhao J and Lyman WD. A
Novel Stem Cell Derived Gene Therapy for HIV/AIDS. A 1031, 1999 Pediatrics
Academic Societies Ann Meeting, San Francisco, May 1-4, 1999.
Thomas
RA, Krishnan M, Zacharova V, Zhao J, Lyman WD. Engineering Human Hematopoietic
Stem Cells to Generate HIV-1 Replication Defective Cells. A 08, Center for Mol
Med Scientific Retreat, Maumee Bay, November 19-20, 1999.
Thomas
RA, Krishnan M, Zacharova V, Zhao J, Lyman WD. Transgene Mediated Gene
Expression in CD34+ Human Hematopoietic Stem Cells. AB-4, Center for Mol Med
Scientific Retreat, Maumee Bay, November 19-20, 1999.
Tomkiel
J, Briscoe A Jr, Wakimoto B, Lindsley D. Genetic
and cytological characterization of a male-specific meiotic mutant that causes
fourth chromosome nondisjunction. 40th
Annual Drosophila Research Conference. Bellevue,
WA. 1999.
Tromp
G, Vongpunsawad S, Kuivaniemi H, Ronkainen A, Hernesniemi J.
Analysis of candidate genes for intracranial aneurysms. Circulation, 99:
1117, 1999.
Wang
X, Tromp G, Kuivaniemi H, Molina L, Serrano de la Pena L and Williams CJ.
Physical and Transcript mapping of the Blau syndrome susceptibility locus. Am J
Hum Genet, 65S: A422, 1999.
Womble
DD. GCG: The Wisconsin Package of Sequence Analysis Programs.
In Bioinformatics Methods and Protocols, Misener S and Krawetz SA, eds.
Totowa, New Jersey: Humana Press, Inc. pp.
3-22.
Womble
DD. Web-Based interfaces for the GCG Sequence Analysis Programs.
In Bioinformatics Methods and Protocols, Misener S and Krawetz SA, eds.
Totowa, New Jersey: Humana Press, Inc. pp. 23-30.
Wykes
S and Krawetz SA. Is DNase
I-hypersensitivity necessary for maintaining open chromatin domains. Center for
Molecular Medicine & Genetics Wayne State University Scientific Retreat
Maumee Bay C 11, 1999.
Yaron
Y, Krivchenia EL, Cole LA, Leon J, Bradford S, Hallak M, Evans MI.
Urinary b-core fragment (BCF) of human chorionic gonadotropin (hCG) as a
predictor of Down syndrome (DS): Comparison
with triple serum marker screening. Society for Maternal Fetal Medicine Annual
Meeting. San Francisco, CA, January
18-23, 1999. American Journal of
Obstetrics and Gynecology, 180:S57, 1999.
Yaron
Y, Jaffa AJ, Har-Toov Y, Amster R, Gull I, Wolman I, Avrashi S, Lessing JB,
Evans MI. First trimester combined screening using nuchal translucency
and maternal serum PAPP-A and free ß-hCG in the detection of chromosomal
anomalies. Society for Gynecologic
Investigation, 46th Annual Meeting. Atlanta, GA, March 10-13, 1999. Journal of
the Society for Gynecologic Investigation, 6:100A, 1999.
Yoon
S, Tromp G, Olson M, Malcom GT, Strong JP and Kuivaniemi H. Association of a
polymorphism in the gene for MMP13 with atherosclerosis. Am J Hum Genet, 65S:
A403, 1999.
Zakarian
VL, Loeb JA. Regulation of
neuregulin expression in embryonic motor neurons by target interactions. Soc Neurosci Abs, 25:770, 1999.
Abstracts
In Press
Al-Aouar
R, Kuivaniemi H, Ronkainen A, Hernesniemi J, Ryynänen M, Majamaa K, Myllylä V,
Myllylä R, Tromp G. Does vasodilator-stimulated phosphorprotein contribute to
risk for intracranial aneurysm? Stroke (in press)
Baker
C, Feldman B, Shalhoub AG, Ayoub MA, Evans MI.
Demographic determinants on the utilization of invasive genetic testing
after multifetal pregnancy reduction (MFPR).
Society for Gynecologic Investigation Annual Meeting, March 22-25, 2000,
Chicago, IL (poster). (in press)
Chik
L, Chik K, Spencer K, Sokol RJ, Krantz D, Johnson A, Macri JN, Evans MI.
An evalatuion of likelihood ratios for Down syndrome from maternal age,
alpha-fetoprotein, and free beta human chorionic gonadotrophin.
Society for Maternal Fetal Medicine Annual Meeting, January 31-February
5, 2000, Miami, FL. (in press)
Evans
MI, Ayoub MA, Shalhoub AG, Feldman B, Yaron Y, Johnson A.
35% of couples declining multifetal pregnancy reduction spontaneously
abort. Society for Gynecologic
Investigation Annual Meeting, March 22-25, 2000, Chicago, IL (poster). (in press)
Evans
MI, Henry G, Miller W, Bui T, Snijders R, Wapner R, Miny P, Johnson M, Peakman
D, Johnson A, Nicolaides K, Holzgreve W, Ebrahim S, Jackson L.
Letter to the Editor. Human
Reproduction. (in press)
Evans
MI, Elias S, Bianchi D, Jackson L, Holzgreve W, de la Cruz F, Wapner RJ, Dukes
KA, Klinger K, Krivchenia EL, Simpson JL. Racial/ethnic
confounders to the detection of Y signals in maternal blood in women carrying
male fetuses: The NIFTY Group
Study. Society for Gynecologic
Investigation Annual Meeting, March 22-25, 2000, Chicago, IL (oral). (in press)
Feldman
B, Dotson LK, Johnson MP, Evans MI, Johnson A.
A comparison of misoprostol with carboprost for induction of second
trimester genetic termination of pregnancy.
Society for Gynecologic Investigation Annual Meeting, March 22-25, 2000,
Chicago, IL (poster). (in press)
Feldman
B, Qureshi F, Jacques SM, Fefalu MJV, Moran O, Shalhoub AG, Johnson MP, Johnson
A, Evans MI. Pathologic analysis of
fetal specimens from dilatation and evacuation (D&E), for second trimester
genetic termination of pregnancy. Society
for Gynecologic Investigation Annual Meeting, March 22-25, 2000, Chicago, IL
(poster). (in press)
Feldman
B, Jacques SM, Qureshi F, Johnson MP, Johnson A, Evans MI.
Postabortion pathologic analysis is hampered by pretreatment induction of
fetal cardiac asystole. Society for
Maternal Fetal Medicine Annual Meeting, January 31-February 5, 2000, Miami, FL.
(in press)
Feldman
GL, Monaghan KG, Barbaratto GM, Snow, K. The
frequency and clinical significance of the S1235R mutation in the Cystic
Fibrosis Transmembrane Conductance Regulator gene: results from a collaborative
study. Genet in Med (in press)
Johnson
A, Abella EM, Kukuruga DL, Whitten-Shurney W, Baynes RD, Lyman WD, Whitten CF,
Evans MI. In-utero transplantation
of paternal CD34 enriched T-cell depleted hematopoietic stem cells for treatment
of sickle cell anemia. Society for
Gynecologic Investigation Annual Meeting, March 22-25, 2000, Chicago, IL
(poster). (in press)
Johnson
A, Tyagi R, Gilbert AD, Stockman PT, Bawle E, Evans MI, Treadwell MC, Zador IE.
Perinatal outcome in prenatally diagnosed situs inversus.
Society for Maternal Fetal Medicine Annual Meeting, January 31-February
5, 2000, Miami, FL. (in press)
Ochshorn
Y, Jaffa AJ, Evans MI, Orr-Urtreger A, Many A, Lessing JB, Yaron Y.
ROC-curve derived lower cutoff for first trioemster PAPP-A:
Increasing sensitivity for non-Down syndrome aneuploidy detection.
Society for Gynecologic Investigation Annual Meeting, March 22-25, 2000,
Chicago, IL (oral). (in press)
Sukkar
N, Flore LA, Mohamed A, Ebrahim SAD, Evans MI, Johnson A.
Detection of a de novo unbalanced cryptic 6;21 translocation by
fluorescence in situ hybridization (FISH) in a fetus with multiple congenital
anomalies. Society for Gynecologic
Investigation Annual Meeting, March 22-25, 2000, Chicago, IL (poster). (in press)
Case
Reports Published
Feldman
B, Kramer RL, Ebrahim SAD, Wolff DJ, Evans MI.
Prenatal evaluation of a de novo X;9 translocation.
American Journal of Medical Genetics 85(5):476-478, 1999.
Kramer
RL, Feldman B, Ebrahim SA, Kasperski SB, Johnson MP, Evans MI.
Molecular cytogenetic analysis of a de novo 5q31q33 deletion associated
with multiple congenital anomalies -a case report. American Journal of Medical Genetics 82:143-145, 1999.
Yaron
Y, Kramer RL, Feldman B, Kasperski SB, Vo T, Feldman GL, Johnson MP, Evans MI,
Ebrahim SA. Prenatal diagnosis of
46,XY/46,XX Mosaicism - A case report.
American Journal of Medical Genetics
84(1):12-14, 1999.
Patents
and Intellectual Property
Lancaster
WD, Gregoire L. ÒUse of Conserved Oligonucleotide Primers to Amplify Human
Papillomavirus DNA SequencesÓ United States patent No. 5,863,717 issued January
26, 1999. (not previously reported).
Letters
to the Editor
Bianchi
DW, Simpson JL, Jackson LG, Evans MI, Elias S, Holzgreve W, Sullivan L, Cruz F,
and DM-STAT on behalf of the NICHD Fetal Cell Study (NIFTY) Group. Letter to the
Editor. Prenatal Diagnosis
19(10):994-995, 1999.
Sokol
AI, Kramer RL, Yaron Y, OÕBrien JE, Muller F, Johnson MP, Evans MI.
Letter to the Editor. American
Journal of Obstetrics and Gynecology 180(6):1598, 1999.
Tsai
C-H, Van Dyke DL and Feldman GL. Reply
to the Letter to the Editor by Zackai-ÓDeletion 4q34.2Ó.
Am J Med Genet 86:198, 1999.
|